David Michael Broussard ED.D.

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

Bronchitis is inflammation of the cells lining your bronchial airways. Bronchitis affects males more than the females. Bronchitis can be due to an infection (viral or bacterial in origin), inhalation of smoke, dust or any other irritating substance....

What Are the Benefits of Drinking Green Tea?Tea is one of the most popular beverages worldwide with millions of people drinking a cup to start the day. There are three main types of tea – green, black and oolong. Green tea, in particular, has been known to have numerous health benefits for...

Although food allergies and food intolerance result in symptoms that are alike, they are different causes. You could be suffering from either of the conditions if after consuming dairy you have gas, diarrhea, bloating, or nausea.The majority of animals that consume milk when they are young naturally...

M 66 PillThis pill is round and yellow in color with an imprint of “M 66”. It has been identified as meloxicam 7.5 mg, which is used for the treatment of inflammatory conditions, fibromyalgia, osteoarthritis, rheumatoid arthritis, and tendonitis.Under the Controlled Substances Act, meloxicam is...

Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...